Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse

Journal of Investigative Dermatology

Volumn 130, Issue 10, 2010, Pages 2359-2367

  Nieves, Nirca J ^a   Ahrens, Jamie M ^a   Plum, Lori A ^a   Deluca, Hector F ^a   Clagett Dame, Margaret ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLENE 18,19 DINOR 1ALPHA,25 DIHYDROXYCOLECALCIFEROL; 2 METHYLENE 19 NOR 1ALPHA HYDROXY BISHOMOPREGNACALCIFEROL; 2 METHYLENE 19 NOR 24 EPI 1ALPHA,25 DIHYDROXYCOLECALCIFEROL; 2 METHYLENE 19,26 DINOR 1ALPHA,25 DIHYDROXYCOLECALCIFEROL; 2 METHYLENE 1ALPHA,25 DIHYDROXY 17(20) DEHYDRO 19 NORCOLECALCIFEROL; CALCITRIOL; CALCIUM; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; 19-NOR-1,24,25-TRIHYDROXYVITAMIN D2; 2-METHYLENE-19-NOR-(20S)-1 ALPHA-HYDROXY-BISHOMOPREGNACALCIFEROL; 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3; DIHYDROXYCOLECALCIFEROL; ERGOCALCIFEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; COMEDO; DOSE RESPONSE; DRUG STRUCTURE; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKINFOLD THICKNESS; UTRICLE; ACNE VULGARIS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; EPIDERMIS; HAIRLESS MOUSE; HYPERKERATOSIS, EPIDERMOLYTIC; ISOMERISM; MUTANT MOUSE STRAIN; PATHOLOGY;

ACNE VULGARIS; ANIMALS; CALCITRIOL; CALCIUM; CELL DIFFERENTIATION; DIHYDROXYCHOLECALCIFEROLS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMIS; ERGOCALCIFEROLS; FEMALE; HYPERKERATOSIS, EPIDERMOLYTIC; ISOMERISM; MALE; MICE; MICE, HAIRLESS; MICE, MUTANT STRAINS;

EID: 77956885936     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.142     Document Type: Article

References (49)

1. rh) induced by retinoids. J Invest Dermatol 82:632-635
2. 3 (2MD) selectively eliminates bone calcium mobilization activity. Bioorganic Med Chem 17:7658-7669
3. Bernerd F, Demarchez M, Ortonne JP et al. (1991a) Sequence of morphological events during topical application of retinoic acid on the rhino mouse skin. Br J Dermatol 125:419-425
4. Bernerd F, Ortonne JP, Bouclier M et al. (1991b) The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones. Arch Dermatol Res 283:100-107
5. Bikle D (2005) Vitamin D: role in skin and hair. In: Vitamin D. 2nd ed. (Feldman D, Pike JW, Glorieux FH, eds), San Diego: Elsevier Academic Press, 609-630
6. Bouclier M, Cavey D, Kail N et al. (1990) Experimental models in skin pharmacology. Pharmacol Rev 42:127-154
7. Bouclier M, Chatelus A, Ferracin J et al. (1991) Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol 4:65-73
8. Degitz K, Ochsendorf F (2008) Pharmacotherapy of acne. Expert Opin Pharmacother 9:955-971
9. DeLuca HF (2008) Evolution of our understanding of vitamin D. Nutr Rev 66:S73-87
10. 3 for the study of specific functions of Vitamin D. J Steroid Biochem Mol Biol 103:263-268
11. Fort-Lacoste L, Verscheure Y, Tisne-Versailles J et al. (1999) Comedolytic effect of topical retinaldehyde in the rhino mouse model. Dermatology 199(Suppl 1):33-35
12. 3. J Dermatol Sci 24:105-111
13. 3: dependence on cell culture conditions. J Invest Dermatol 106:510-516
14. 3 hormone, on hairless mouse skin in vivo. Br J Dermatol 132:841-852
15. 3. Biochem Pharmacol 49:621-624
16. Gollnick H (2003) Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 63:1579-1596
17. Haussler MR, Haussler CA, Bartik L et al. (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66:S98-112
18. 3 analogue on pseudocomedones in the rhino mouse. Br J Dermatol 155:895-901
19. Holick MF (1994) McCollum Award Lecture, 1994: Vitamin D-new horizons for the 21st century. Am J Clin Nutr 60:619-630
20. 3. Endocrinology 113:1950-1957
21. Hsieh JC, Sisk JM, Jurutka PW et al. (2003) Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 278: 38665-38674
22. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231
23. Kimball AB (2008) Advances in the treatment of acne. J Reprod Med 53:742-752
24. Kligman LH, Kligman AM (1979) The effect on rhino mouse skin of agents which influence keratinization and exfoliation. J Invest Dermatol 73:354-358
25. Krämer C, Seltmann H, Seifert M et al. (2009) Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol 113:9-16
26. Langner A, Verjans H, Stapor V et al. (1993) Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol 128:566-571
27. Levy J, Gassmuller J, Schroder G et al. (1994) Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 7:231-236
28. Li YC, Pirro AE, Amling M et al. (1997) Targeted ablation fo the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
29. Mann SJ (1971) Hair loss and cyst formation in hairless and rhino mutant mice. Anat Rec 170:485-499
30. Mezick JA, Bhatia MC, Capetola RJ (1984) Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify "antikeratinizing" effects of retinoids. J Invest Dermatol 83:110-113
31. Mezick JA, Bhatia MC, Shea E et al. (1985) Anti-acne activity of retinoids in the rhino mouse. In: Models in Dermatology, Vol.2. (Maibach HI, Lowe NJ, eds), Basel: Karger, 59-63
32. Mirshahpanah P, Maibach HI (2007) Models in acnegenesis. Cutan Ocul Toxicol 26:195-202
33. Osborn JL, Schwartz GG, Smith DC et al. (1995) Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol Oncol 1:195-198
34. Pillai S, Bikle DD, Elias PM (1988) 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263:5390-5395
35. Plum LA, Prahl JM, Ma X et al. (2004) Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. Proc Natl Acad Sci USA 101:6900-6904
36. Reichrath J, Muller SM, Kerber A et al. (1997) Biologic effects of topical calcipotriol (MC903) treatment in psoriatic skin. J Am Acad Dermatol 36:19-28
37. Rochel N, Wurtz JM, Mitschler A et al. (2000) The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173-179
38. Sakuta T, Kanayama T (2005) Comedolytic effect of a novel RARgamma-specific retinoid, ER36009: comparison with retinoic acid in the rhino mouse model. Eur J Dermatol 15:459-464
39. 3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. J Med Chem 41:4662-4674
40. 3 compounds with modified side chain: 26,27-dihomo-and 26,27-dimethylene analogs in 20S-series. Steroids 67:247-256
41. Skorija K, Cox M, Sisk JM et al. (2005) Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol 19:855-862
42. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-1190
43. Tocchini-Valentini G, Rochel N, Wurtz JM et al. (2001) Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 98:5491-5496
44. Van Scott EJ (1972) Experimental animal integumental models for screening potential dermatologic drugs. Adv Biol Skin 12:523-533
45. 3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry 43:4101-4110
46. 3 with conformation-ally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations. Arch Biochem Biophys 460:161-165
47. Yoshizawa T, Handa Y, Uematsu Y et al. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396
48. Zarach JM, Beaudoin GMJ III, Coulombe PA et al. (2004) The co-repressor hairless has a role in epithelial cell differentiation in the skin. Development 131:4189-4200
49. Zheng P, Gendimenico GJ, Mezick JA et al. (1993) Topical all-trans retinoic acid rapidly corrects the follicular abnormalities of the rhino mouse. An ultrastructural study. Acta Dermatol Venereol 73:97-101